Postmenopausal endometriosis

Acta Obstetricia et Gynecologica Scandinavica

Volumn 86, Issue 10, 2007, Pages 1158-1164

  Oxholm, Dorthe ^a   Knudsen, Ulla Breth ^a   Kryger Baggesen, Niels ^a   Ravn, Pernille ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Estrogen; Hormonal replacement therapy; Malignant transformation; Postmenopausal endometriosis

Indexed keywords

ANASTROZOLE; ESTRADIOL; ESTROGEN; GESTAGEN; GONADORELIN DERIVATIVE; HORMONE; LETROZOLE; PROGESTERONE; TESTOSTERONE; TIBOLONE;

AWARENESS; CANCER RISK; ENDOMETRIOSIS; EXPERIENCE; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; MEDICAL LITERATURE; MEDLINE; MENOPAUSAL SYNDROME; MENOPAUSE; OVARIECTOMY; OVARY; OVARY CANCER; POSTMENOPAUSAL ENDOMETRIOSIS; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; STIMULATION;

AGED; ENDOMETRIOSIS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; POSTMENOPAUSE; RISK;

EID: 34648818924     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340701619407     Document Type: Review

References (43)

1. Giudice LC, Kao LC. Endometriosis. Lancet. 2004;364:1789-99.
2. Henriksen E. Endometriosis. Am J Surg. 1955;90:331-7.
3. Ranney B. Endometriosis. III. Complete operations. Am J Obstet Gynecol. 1971;109:1137-44.
4. Punnonen R, Klemi PJ, Nikkanen V. Postmenopausal endometriosis. Eur J Obstet Gynecol Reprod Biol. 1980;11(3):195-200.
5. Schenken RS. Endometriosis. Lippincott; 1989.
6. Kemper RD, Dockerty MB, Hunt AB, Symmonds RE. Significant postmenopausal endometriosis. Surg Gynecol Obstet. 1960;(111):348-56.
7. Rattanachaiyanont M, Angsuwatthana S, Inthawiwat S, Tanmahasamut P, Techatraisak K, Leerasiri P. Hormonal replacement therapy in surgical menopause with underlying endometriosis. J Med Assoc Thai. 2003;86(8):702-7.
8. Hulka BS. Links between hormone replacement therapy and neoplasia. Fertil Steril. 1994;62(6 suppl 2):168S-75S.
9. Barbieri RL. Etiology and epidemiology of endometriosis. Am J Obstet Gynecol. 1990;162(2):565-7.
10. Toki T, Horiuchi A, Li SF, Nakayama K, Silverberg SG, Fujii S. Proliferative activity of postmenopausal endometriosis: a histopathologic and immunocytochemical study. Int J Gynecol Pathol. 1996;15(1):45-53.
11. Vorstman B, Lynne C, Politano VA. Postmenopausal vesical endometriosis. Urology. 1983;22(5):540-2.
12. Kurioka H, Takahashi K, Okada M, Ozaki T, Miyazaki K, Maruyama R, et al. A case of postmenopausal endometriosis unrelated to neoplasm. Int J Fertil Womens Med. 1999;44(3):160-2.
13. Deval B, Rafii A, Dachez M, Kermanash R, Levardon M. Sigmoid endometriosis in a postmenopausal woman. Am J Obstet Gynecol. 2002;187(6):1723-5.
14. Djursing H, Petersen K, Weberg E. Symptomatic postmenopausal endometriosis. Acta Obstet Gynecol Scand. 1981;60(5):529-30.
15. Habuchi T, Okagaki T, Miyakawa M. Endometriosis of bladder after menopause. J Urol. 1991;145(2):361-3.
16. Redwine DB. Endometriosis persisting after castration: clinical characteristics and results of surgical management. Obstet Gynecol. 1994;83:405-13.
17. Henderson AF, Studd JWW, Watson N. A retrospective study of oestrogen replacement therapy following hysterectomy for the treatment of endometriosis. In: Shaw RW, ed. Advances in reproductive endocrinology. Casterton Hall, Carnforth, Lancaster: Parthenon; 1990. p. 131-8.
18. Venter PF, Anderson JD, van Velden DJ. Postmenopausal endometriosis. S Afr Med J. 1979;56(26):1136-8.
19. Choi SW, Lee HN, Kang SL, Kim HO. A case of cutaneous endometriosis developed in a postmenopausal woman receiving hormonal replacement. J Am Acad Dermatol. 1999;41:327-9.
20. Jelovsek JE, Winans C, Brainard J, Falcone T. Endometriosis of the liver containing mullerian adenosarcoma: case report. Am J Obstet Gynecol. 2004;191:1725-7.
21. Takayama K, Zeitoun K, Gunby RT, Sasano H, Carr BR, Bulun SE. Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. Fertil Steril. 1998;69(4):709-13.
22. Fatemi HM, Al-Turki HA, Papanikolaou EG, Kosmas L, DeSutter P, Devroey P. Successful treatment of an aggressive recurrent postmenopausal endometriosis with an aromatase inhibitor. Reprod Biomed Online. 2005;11(4):455-7.
23. Matorras R, Elorriaga MA, Pijoan JI, Ramón O, Rodriguez-Escudero FJ. Recurrence of endometriosis in women with bilateral adnexectomy (with or without total hysterectomy) who received hormone replacement therapy. Fertil Steril. 2002;77(2):303-8.
24. Fedele L, Bianchi S, Raffaelli R, Zanconato G. Comparison of transdermal estradiol and tibolone for the treatment of oophorectomized women with deep residual endometriosis. Maturitas. 1999;32(3):189-93.
25. Hickman T, Namnoum AB, Hinton EL, Zacur HA, Rock JA. Timing of oestrogen replacement therapy following hysterectomy with oophorectomy for endometriosis. Obstet Gynecol. 1998;91(5 Pt1):673-7.
26. Sampson JA. Endometrial carcinoma of the ovary arising in endometrial tissue in that organ. Arch Surg. 1925;10:1-72.
27. Brinton L, Gridley G, Persson I, Baron J, Bergqvist A. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol. 1997;176(3):572-9.
28. Borgfeldt C, Andolf E. Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis. Acta Obstet Gynecol Scand. 2004;83:395-400.
29. Mengersen KL, Merrilees MJ, Tweedie RL. Environmental tobacco smoke and ischaemic heart disease: a case study in applying causal criteria. Int Arch Occup Environ Health. 1999;72 Suppl:R1-40.
30. Somigliana E, Vigano P, Parazzini F, Stoppelli S, Giambattista E, Vercellini P. Association between endometriosis and cancer: a comprehensive review and critical analysis of clinical epidemiological evidence. Gynecol Oncol. 2006;101(2):331-41.
31. Melin A, Sparen P, Persson I, Bergqvist A. Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod. 2006;21(5):1237-42.
32. Bertelsen L, Mellemkjær L, Frederiksen K, Kjær SK, Brinton LA, Sakoda L, et al. Risk for breast cancer among women with endometriosis. Int J Cancer. 120:1372-5.
33. Ness RB. Endometriosis and ovarian cancer: thoughts on shared pathophysiology. Am J Obstet Gynecol. 2003;189(1):280-94.
34. Modugno F, Ness RB, Allen GO, Schildkraut JM, Davis FG, Goodman MT. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis. Am J Obstet Gynecol. 2004;191(3):733-40.
35. Lavery S, Gillmer M. Malignant transformation of residual endometriosis in women on unopposed oestrogen hormone replacement therapy. BJOG. 2001;108(10):1106-7.
36. Debus G, Schuhmacher I. Endometrial adenocarcinoma arising during estrogenic treatment 17 years after total abdominal hysterectomy and bilateral salpingo-oophorectomy: a case report. Acta Obstet Gynecol Scand. 2001;80(6):589-90.
37. Van Gorp T, Neven P. Endometrial safety of hormone replacement therapy: review of literature. Maturitas. 2002;42(2):93-104.
38. Heaps JM, Nieberg RK, Berek JS. Malignant neoplasms arising in endometriosis. Obstet Gynecol. 1990;75(6):1023-8.
39. Zanetta GM, Webb MJ, Li H, Keeney GL. Hyperestrogenism: a relevant risk factor for the development of cancer from endometriosis. Gynecol Oncol. 2000;79:18-22.
40. Gücer F, Pieber D, Arikan G. Malignancy arising in extraovarian endometriosis during estrogen stimulation. Eur J Gynaecol Oncol. 1998;19(1):39-41.
41. Modesitt SC, Tortolero-Luna G, Robinson JB, Gershenson DM, Wolf JK. Ovarian and extraovarian endometriosis-associated cancer. Obstet Gynecol. 2002;100(4):788-95.
42. McCluggage WG, Bryson C, Lamki H, Boyle DD. Benign, borderline, and malignant endometrioid neoplasia arising in endometriosis in association with tamoxifen therapy. Int J Gynecol Pathol. 2000;19(3):276-9.
43. Bese T, Simsek Y, Bese N, Ilvan S, Arvas M. Extensive pelvic endometriosis with malignant change in tamoxifen-treated postmenopausal women. Int J Gynecol Cancer. 2003;13(3):376-80.